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Internalised stigma in people with
rheumatoid arthritis: a cross sectional
study to establish the psychometric
properties of the ISMI-RA
Elizabeth Corker1*, R. Claire Henderson2, Heidi Lempp3 and June S. L. Brown1
Abstract
Background: Internalised stigma is theorized to be the internalisation and legitimisation of stereotypes of the
diagnosis held in society and has not been quantified within patients with Rheumatoid Arthritis. This study aimed
to: validate a modified version of a measure of internalised stigma, (the Internalised Stigma of Mental Illness scale,
ISMI) for use in a group of patients diagnosed with rheumatoid arthritis; establish the consistency of the construct
being measured, and to explore the levels of internalised stigma within this group.
Methods: A cross-sectional survey was conducted in London, UK with participants receiving out-patient treatment
for Rheumatoid Arthritis. Participants completed the ISMI-Rheumatoid Arthritis (ISMI-RA) and a measure of self-esteem.
Results: One hundred respondents were interviewed by phone. The ISMI-RA was found to be reliable using a
measure of internal consistency (α = 0.85) showed concurrent validity with the Index of Self Esteem (r = 0.58,
p < 0.01) and discriminant validity with no association with gender (t = 1.43, p = 0.61). A quarter of respondents
reported internalised stigma to a ‘severe’ level. Acceptability and feasibility were established. A confirmatory
factor analysis provided some support for the model of internalised stigma.
Conclusions: The application of the ISMI-RA among the Rheumatoid Arthritis population looks promising.
Internalised stigma was found to be present within this group. More research is needed to generalize these
results and to explore the effects of internalised stigma on treatment adherence and quality of life.
Keywords: Internalised stigma, Rheumatoid Arthritis, Methodology
Background
Rheumatoid Arthritis (RA) is a long-term inflammatory
autoimmune disease. RA affects joints and tendons, and
commonly results in joint stiffness, swelling and soreness
[1]. It is estimated that around 1 % of the UK adult popula-
tion have RA [2]. The female to male ratio is 3:1 [2–4] and
onset is most likely in early middle age [2, 5]. Finally, RA
has been found to be more common in people from a
European, as opposed to an Asian background [3, 6].
RA also affects mortality. Although those diagnosed
mainly die of similar causes compared to the general
population, this usually happens three to ten years earl-
ier than expected [7–9], mostly due to cardiovascular
disease [1].
Against a background of long term disability when living
with RA, stigma has also been identified as a social
phenomenon amongst this population [4, 10]. Recent
research has begun to differentiate between specific types
of stigma. Firstly, public (or perceived) stigma which refers
to the attitudes and behaviour of other people towards
those with the stigmatised diagnosis or identity [11]. One
study has found evidence of perceived stigma in people
with a diagnosis of RA [10], whilst in another, participants
reported feeling publically stigmatised because of their RA
diagnosis and associated problems such as deformities and
walking slowly [4]. Secondly, self stigma, (also known as
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internalised stigma), is defined as the awareness, legitim-
isation and application of societal stereotypes of the par-
ticular stigmatised diagnosis to the self, and may result in
decreased self-esteem and self-efficacy [12]. In terms of
public stigma, some long term health diagnosis are linked
to a stigmatised identity [13] and can cause discrimination
in many areas of life, such as healthcare, employment,
education and personal relationships [14–16]. Addition-
ally, negative attitudes are held towards those who have a
physical disability that is caused by an illness, rather than
an injury [17]. These stigmatising attitudes have been
described as more difficult to deal with than the illness
itself [18]. Relatively high levels of public stigma have been
reported in RA [10].
With regards to internalised stigma, the focus of research
was initially on people who live with a mental illness diag-
nosis. The Internalised Stigma of Mental Illness (ISMI)
scale is commonly utilized to measure this construct [19].
However, the ISMI has now been validated for use in some
physical health populations [20], including leprosy [21, 22],
HIV/AIDS [22], irritable bowel syndrome [23] and epilepsy
[24]. Available psychometric data for these modifications
suggest that these adapted measures are reliable in these
groups [21, 22] and demonstrate that a third of a stigma-
tized population will report moderate or high internalised
stigma [23, 25]. High levels of internalized stigma, are asso-
ciated with low degree of self esteem [12], help seeking [26]
and treatment adherence [27].
Psychometric validation however, is limited with the
ISMI. The authors found only one study, based on a sample
with mental illness, which studied construct validity using
Factor Analysis and measurement invariance [28], ensuring
that the same construct, that is, internalised stigma has
being measured across time.
The existence of internalised stigma in people with a
diagnosis of RA has not been quantified. The impact of
RA on identity, and concerns about stigma have been
explored in a qualitative study [4]. This study found that
people with RA have to reconcile their previous roles
within private and public spheres with their new identity
as a person diagnosed with RA. This is seen to cause
emotional distress and role conflicts, such as when a
formerly independent person or someone who has been
a parent or carer then has to accept help from others.
The aims of this study were threefold. Firstly, to validate
a modified version of the ISMI in people with a diagnosis
of RA (to be called ISMI-RA), and establish (i) its reliabil-
ity; (ii) its concurrent validity; (iii) its discriminant validity
and to determine (iv) its acceptability and (v) feasibility.
The second aim is to further validate the ISMI-RA and
carry out a confirmatory factor analysis (CFA) to establish
the consistency of the construct being measured. Finally,
we wanted to explore levels of internalised stigma, using
the ISMI-RA, within an RA outpatient clinic population.
Given the previous literature regarding internalised stigma
in various health conditions, we predicted that internalised
stigma would be present in levels above ‘minimal’ [29] in
around 30 % of this RA group.
Methods
A cross-sectional study was conducted between January
2013 and September 2013 in London, UK. A convenience
sample was chosen to recruit participants from two hospi-
tals in London. The inclusion criteria were: (i) attendance
of a rheumatology outpatient clinic at one of the two sites;
(ii) had received a diagnosis of RA (early or established) by
a consultant rheumatologist; (iii) aged 16–65; (iv) English
speaking, and (v) were not an inpatient at the time of the
study. Patients who were diagnosed before 2010 (n = 77)
met the American College of Rheumatology criteria for RA
[30], whereas those diagnosed after 2010 (n = 23) met the
revised American College of Rheumatology and European
League against Rheumatism criteria for RA [31]. Potential
participants were identified by a research nurse, who
screened for eligibility and briefly explained the project after
a routine appointment. If patients expressed an interest to
take part, the researcher then explained the project in more
detail and gave them an envelope, which included informa-
tion about the study, a consent form and sources of add-
itional support. Outpatient attendees took the documents
away to read and return the signed consent form to the
researcher once they were ready to take part and agreed to
be interviewed by telephone.
Instruments
The internalised stigma of mental illness scale
The Internalised Stigma of Mental Illness scale (ISMI)
[19] was developed to measure the subjective experience
of stigma in collaboration with mental health service
users. Five subscales (alienation, stereotype endorsement,
perceived discrimination, social withdrawal and stigma
resistance) with a total of 29 items are rated by partici-
pants on a four point Likert scale. The scale has good
internal reliability in a sample of people with psychiatric
illnesses (α = 0.90) and test-retest reliability (r = 0.92). For
the present study, all references to ‘mental illness’ were
replaced with ‘rheumatoid arthritis’. Additionally, one
item, “people with mental illness tend to be violent” was
removed. Permission to modify the ISMI was granted from
the authors. Finally, as recommended in previous studies,
the stigma resistance subscale was removed from the
analysis, as it has been found to be a separate construct to
internalized stigma [28, 32]. Higher scores indicate higher
internalised stigma: a score between 1.00 and 2.00 indicates
minimal or no internalised stigma; 2.01–2.50 indicates mild
internalised stigma, 2.51–3.00 indicates moderate interna-
lised stigma and 3.01–4.00 indicates severe internalised
stigma [29]. A two category scoring system is used by the
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author of the scale in a review of the use of the ISMI, in
which scores below 2.50 are classified as ‘low internalised
stigma’ and scores equal to or above 2.51 are classified as
‘high internalised stigma’ [20], this scoring system was used
in the present analysis.
The index of self esteem
The Index of Self Esteem (ISE) [33] measures the self evalu-
ative aspect of self- esteem. Participants rate 25 items that
relate to self- esteem on a seven point Likert scale with a
total possible score of 100. The Walmyr Assessment Scales
Scoring Manual was used to categorise the raw scores.
Higher scores indicate lower self-esteem. A score of 30 and
above indicates self esteem difficulties and scores over 70
indicate severe self- esteem problems.
Statistics
Data were entered into IBM SPSS (v.20). The confirma-
tory factor analysis was conducted using AMOS (v.20); all
other analyses were conducted using IBM SPSS (v. 20).
Internal reliability was established to determine Cron-
bach’s alpha’s for each ISMI-RA subscale and the total
score. Concurrent validity was tested with a Pearson’s cor-
relation between the total ISMI-RA and subscale scores
and the ISE. Although the ISE measures self- esteem which
would be theorised to have a negative association with
internalised stigma, the scoring of the ISE is such that
higher score indicates low self esteem, therefore the direc-
tion of the association is appropriate for a concurrent valid-
ity test. This variable was selected as a measure of divergent
validity as it is expected that ISMI-RA scores will not have
a significant association with gender. No significant differ-
ence in ISMI-RA scores by gender will be taken as the
appropriate criterion. Feasibility was assessed by timing the
duration to complete the ISMI-RA. Over 30 min (mean
average) is considered to be too long for a survey measure
[34]. Acceptability was examined by measuring floor and
ceiling effects that would violate Maximum Endorsement
Frequencies (MEF); if more than 15 % of participants
scored in the highest and lowest categories, this would be a
violation of MEF [35]. A CFA was performed to study the
factor structure of the latent construct of internalised
stigma [36]. A CFA was deemed an appropriate test for
model fit, as the manifest variables have been previously de-
fined in the literature, and the present study aimed to assess
these variables with regards to an RA population. Manifest
variables in the model were Alienation, Stereotype Endorse-
ment, Discrimination Experience and Social Withdrawal,
the latent construct was self stigma. Model fit was assessed
with multiple fit statistics; the goodness of fit index (GFI),
the root mean square error of approximation (RMSEA)
and the goodness of fit chi-square. Model fit would be
supported if the GFI, RMSEA and goodness of fit did not
reach statistical significance.
Results
A total of 100 respondents were included in the study;
25 males and 75 females (see Table 1). A total of 127 out
patients eligible to participate were approached for con-
sent, 27 out patients declined to take part, yielding a re-
sponse rate of 79 %. Reasons for non-participation were
not sought. The mean age of the group was 46.3 years
(SD: 10.9; range 23–65). The majority of the sample self-
described themselves as white British (75.2 %) and over
half were either in work full time (36.6 %), or part time
(27.7 %). The mean number of years since the first contact
with RA services was 6.0 years (SD: 6.1; range 1–31).
The internalised stigma of mental illness scale
Overall, 25 % of the sample reported moderate or severe
levels of internalised stigma. A further 49 % reported mild
levels of internalised stigma. As summarised in Table 2,
the mean total score for the ISMI-RA was 2.2 (SD: 0.36;
range: 1.04–3.13). This is comparable to scores found in
participants with HIV/AIDS (2.3) and leprosy (2.2) [22].
ISMI-RA subscale scores are shown in Table 2. Mean
Table 1 Socio-demographic characteristics of participants
Characteristic Participants (n = 100)
Gender n (%)
Male 25 (25.0)
Female 75 (75.0)
Age (years)
Range 23–65
Mean (SD) 46.3 (10.9)
Years since first contact with RA services
Range 1–31
Median (SD) 6.0 (6.1)
Ethnicity n (%)
White British 76 (76.0)
Other White 9 (9.0)
Black or Mixed Black & White 7 (7.0)
Asian or Mixed Asian & White 5 (5.0)
Other Mixed 0
Other 1 (1.0)
Did not wish to disclose 2 (2.0)
Employment status n (%)
Unemployed 8 (8.0)
Part-time employed 28 (28.0)
Full-time employed 37 (37.0)
Retired 23 (23.0)
Volunteering 0
Training/education 2 (2.0)
Other (incl. Self-employed) 2 (2.0)
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scores ranged from 2.0 (stereotype endorsement) to 2.7
(alienation).
Profile of internalised stigma
Frequency of agreement of items ranged from 0 %
(people with RA should not get married) to 77 % (people
without RA could not possibly understand me). The
most frequently endorsed (that is, agreed with) items
were: people without RA could not possibly understand
me (77 %); I am disappointed in myself for having RA
(67 %); I am embarrassed or ashamed that I have RA
(56 %); I feel inferior to others who don’t have RA
(52 %) and people can tell that I have RA by the way I
look (51.5 %), see Table 3 for further details. Four of the
five most frequently endorsed items belonged to the
alienation subscale, the remaining one belonged to the
stereotype endorsement subscale.
By contrast, the least frequently endorsed items were:
people with RA should not get married (0 %); because I
have RA, I need others to make most decisions for me
(3 %); nobody would be interested in getting close to me
because I have RA (9 %); people ignore me, or take me less
seriously because I have RA (11 %) and stereotypes about
people with RA apply to me (13 %). Three of the five least
frequently endorsed items belonged to the stereotype en-
dorsement subscale, the remaining two from the discrimin-
ation experience subscale.
The index of self esteem
Table 2 illustrates the mean total score for the ISE was 36.8
(SD: 10.2; range: 12.0–60.7) and had an internal consistency
of α = 0.95.
Reliability of ISMI-RA
The Cronbach’s alpha value indicating internal consistency
for the total ISMI-RA was α = 0.85. The subscales ranged
from α = 0.49 (stereotype endorsement) to α = 0.90 (alien-
ation), see Table 2. All alpha values were within the ac-
cepted range for internal consistency [37, 38].
Acceptability of ISMI-RA
Fewer than 15 % of respondents scored in the bottom or
top categories of the ISMI- RA total or any of the sub-
scales (see Table 2), which demonstrates a lack of floor or
ceiling effects respectively using MEF assumptions [35].
Feasibility of ISMI-RA
The mean time to complete the ISMI-RA was 8 min,
which is considered an acceptable duration. Twenty six
out of 28 items contained no missing data, for the
remaining two items, one participant’s data was missing.
Concurrent validity
A Pearson’s correlation revealed a significant, positive cor-
relation between the total ISMI-RA score and the ISE score
(r = 0.58, p < 0.01). Significant, positive correlations were
also found between the ISE and all ISMI-RA subscales:
stereotype endorsement and the ISE (r = 0.48, p < 0.01);
alienation and the ISE (r = 0.48, p < 0.01); discrimination
experience and the ISE (r = 0.48, p < 0.01) and social with-
drawal and the ISE (r = 0.48, p < 0.01).
Confirmatory factor analysis
The path diagram with factor loading (standard regression
weights) is displayed in Fig. 1. All manifest variables (rect-
angles in Fig. 1) were found to be good indicators of the
latent factor (internalised stigma, displayed as an oval in
Fig. 1), weights ranged from 0.63 to 0.96, all p values were
<0.001. The overall model had a chi-square value of 11.2
(df = 2), p = 0.004.
However, the goodness-of-fit test was significant, which
does not support the fit between our hypothesised model
and the data. On the other hand, the GFI provided sup-
port for model fit (0.91) but the RMSEA did not (0.29).
Discussion
Similar to previous studies that have modified the ISMI
for leprosy, HIV/AIDS and inflammatory bowel disease
[21–23], we have found that the modified version of the
ISMI is probably acceptable for use in patients with a
diagnosis of Rheumatoid Arthritis: all Cronbach’s alpha’s
were acceptable; there were no floor or ceiling effects; the
Table 2 Measures of reliability for ISMI-RA
Measure Mean (SD) Range Internal consistency (α) Top/bottom scores (% of pts)
ISMI Top Bottom
Total 2.2 (0.36) 1.04–3.13 0.85 1 1
Alienation 2.7 (0.61) 1.17–4.00 0.90 1 2
Stereotype endorsement 2.0 (0.26) 1.00–2.67 0.49 2 1
Social withdrawal 2.2 (0.45) 1.00–3.33 0.82 1 1
Discrimination experience 2.1 (0.32) 1.00–3.00 0.65 2 1
ISE 36.8 12.0–60.7 0.95 2 1
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Table 3 Endorsement frequencies and completeness of ISMI-RA
items
ISMI-RA item Response n (%)
I feel out of place in the
world because I have RA
Disagree 60 (60.0)
Agree 40 (40.0)
Missing 0
People discriminate against
me because I have RA
Disagree 80 (80.0)
Agree 20 (20.0)
Missing 0
I avoid getting close to
people who don’t have
RA to avoid rejection
Disagree 77 (77.0)
Agree 23 (23.0)
Missing 0
I am embarrassed or
ashamed that I have RA
Disagree 44 (44.0)
Agree 56 (56.0)
Missing 0
People with RA should
not get married
Disagree 100 (100.0)
Agree 0
Missing 0
People with RA make
important contributions
to society
Disagree 14 (14.0)
Agree 86 (86.0)
Missing 0
People with RA make
important contributions
to society
Disagree 14 (14.0)
Agree 86 (86.0)
Missing 0
I feel inferior to others
who don’t have RA
Disagree 48 (48.0)
Agree 52 (52.0)
Missing 0
I do not socialize as much
as I used to because my
RA might make me look
or behave in a “strange”
way
Disagree 69 (69.0)
Agree 31 (31.0)
Missing 0
People with RA cannot
live a good, rewarding
life
Disagree 80 (80.0)
Agree 20 (20.0)
Missing 0
Negative stereotypes against
people with RA like myself
keep me isolated from the
“normal” world
Disagree 81(81.0)
Agree 19 (19.0)
Missing 0
Being around people who
do not have RA makes me
feel out of place or inadequate
Disagree 49 (49.0)
Agree 51 (51.0)
Missing 0
I feel comfortable being seen
in public who obviously has RA
Disagree 13 (49.0)
Agree 87 (87.0)
Missing 0
People often patronise me,
or treat me like a child, just
because I have RA
Disagree 84 (84.0)
Agree 16 (16.0)
Missing 0
Disagree 33 (33.0)
Table 3 Endorsement frequencies and completeness of ISMI-RA
items (Continued)
I am disappointed in myself
for having RA
Agree 67 (67.0)
Missing 0
Having RA has spoiled my life Disagree 51 (51.0)
Agree 49 (49.0)
Missing 0
People can tell that I have
RA by the way I look
Disagree 48 (48.5)
Agree 51 (51.5)
Missing 1
Because I have RA, I need
others to make most
decisions for me
Disagree 97 (97.0)
Agree 3 (3.0)
Missing 0
I stay away from social
situations in order to protect
my family or friends from
embarrassment
Disagree 74 (74.0)
Agree 26 (26.0)
Missing 0
People without RA could
not possibly understand me
Disagree 23 (23.0)
Agree 77 (77.0)
Missing 0
People ignore me or take
me less seriously just
because I have RA
Disagree 89 (89.0)
Agree 11 (11.0)
Missing 0
I cannot contribute anything
to society because I have RA
Disagree 82 (82.0)
Agree 18 (18.0)
Missing 0
Living with RA has made
me a tough survivor
Disagree 58 (58.0)
Agree 42 (42.0)
Missing 0
Nobody would be interested
in getting close to me because
I have RA
Disagree 91 (91.0)
Agree 9 (9.0)
Missing 0
In general, I am able to live
life the way I want to
Disagree 29 (29.0)
Agree 71 (71.0)
Missing 0
I can have a good, fulfilling
life, despite my RA
Disagree 23 (29.0)
Agree 77 (77.0)
Missing 0
Others think that I cannot
achieve much in life
because I have RA
Disagree 85 (85.9)
Agree 14 (14.1)
Missing 1
Stereotypes about RA
apply to me
Disagree 87 (87.0)
Agree 13 (13.0)
Missing 0
I don’t talk about myself
much because I don’t
want to burden others
with my RA
Disagree 77 (77.0)
Agree 23 (23.0)
Missing 0
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duration of administration of the measure was feasible;
concurrent validity was found with self-esteem; discrimin-
ant validity was found with a lack of association with
gender. Although concurrent validity was assessed with a
measure of self- esteem, we are confident that because of
the direction of scoring with the ISE, that this provides
the positive association required for establishing concur-
rent validity. With regards to the second aim, the CFA
provided some support that the subscales were indices of
one factor, the latent construct, internalised stigma even
though not all the goodness of fit measures supported the
model. As a CFA usually assumes multidimensionality,
and self stigma has been suggested to be a construct con-
taining different dimensions [39], this was an appropriate
test for model fit. Finally, we wanted to explore levels of
internalised stigma within an RA outpatient population.
The results showed that 25 % of the group displayed
severe or moderate levels of internalised stigma and a
further 49 % displayed a mild level. This was a higher pro-
portion than our prediction that internalised stigma would
be present in around 30 % of this RA group. Additionally,
the mean scores of the total ISMI-RA were comparable to
previous studies that explored levels of internalised stigma
in HIV/AIDS, leprosy and mental illness [22, 40]. Our
results support previous findings, that suggest that people
with a long term health diagnosis experience stigma and
discrimination [13–16], and that people diagnosed with RA
specifically encounter stigma and discrimination [10]; 20 %
of participants reporting that other people had discrimi-
nated against them, and 17 % feeling patronized because of
their RA.
We expected stereotype endorsement to be a key feature
in the profile of the ISMI-RA results, as this has been
theorized to be a major component of internalised stigma,
[12, 41, 42]. However, the mean score for the stereotype
endorsement subscale was 2.0, which falls within the ‘mild’
internalised stigma classification [19]. Furthermore, this
subscale had the lowest mean score. This pattern has been
found in previous studies that report subscale scores, for
mental illness [43, 44] and inflammatory bowel disease
[23]. Taken together, these results indicate that stereotype
endorsement may not be the key component within self
stigma in patients with RA. The highest subscale score in
this study was alienation, which fell into the ‘moderate’
internalised stigma classification. In previous studies that
focused on patients with a diagnoses of physical long-term
conditions, the most endorsed subscale is usually found to
be social withdrawal or alienation [23, 43, 44]. The current
study supports this pattern.
The results from the current study support work con-
ducted by Lempp and colleagues who found that having
a diagnosis of RA impacted upon a person’s identity and
their roles within society as well as their private lives [4].
Relevant items such as: “having RA has spoiled my life”,
“I don’t socialize as much as I used to because of my RA”
and, “I cannot contribute anything to society because I
have RA”, were endorsed by sizable proportions of the
sample (49 %, 31 % and 18 % respectively) and suggests
that an RA diagnosis can impact on several different as-
pects of the participants’ lives.
Strengths and limitations
This is the first study that has quantified internalised stigma
in a group of people who live with early and established
RA. Additionally, we have successfully modified the ISMI
to extend the scale further within this patient group. The
main limitation was within the CFA, with some of the
fitness indices that indicated that the data was not a good
fit of the model. In order to sufficiently power a CFA, it is
recommended that data from at least 200 participants are
analysed [45, 46]. Due to time and resource constraints, we
were only able to interview 100 participants. We conclude
however that due to the results of the other validation tests
and the model analysis that the ISMI-RA is promising for
application in a population with RA. Additionally, we
would suggest that future studies assess the test-retest
reliability of the ISMI-RA in order to assess for reliability of
the scale over time.
Finally, all our participants were receiving care from a
specialist out-patient NHS clinic in a relatively wealthy
and ethnically diverse city in a high income country.
Our results may therefore not be generalisable to people
Fig. 1 Confirmatory factor analysis model
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who receive services in middle or low income countries
or do not receive any services at all. It may be reason-
able to predict that these populations would report
higher internalised stigma related to their RA. On the
other hand, it may also be the case that in places where
the treatment of RA is not as developed that people di-
agnosed with RA may not conceptualise it as part of
their identity and therefore not experience internalised
stigma [42] to the same degree as identified in this study.
Unfortunately, we do not know how our sample differed
from people who did not take part. The original ISMI
was developed in a Veterans Administration hospital
within the US in an outpatient clinic population with
mental illness, the majority of whom were male (Ritsher
et al. [19]). Since its inception, the ISMI has been
adapted for use across a range of illnesses, languages
and cultures, and has been found to be reliable and
valid [20].
Further research
Generalization could be improved by recruiting participants
from a selection of urban and rural locations. Additional
measures could also be utilized to explore the effect of
internalised stigma on treatment adherence, perceptions of
disability and quality of life.
Patients who received a diagnosis of RA before the intro-
duction of new treatment options such as biologics tend to
have more visible deformities and therefore may experience
more stigma and discrimination [4] and we suggest that
further work needs to explore the effects of visible deform-
ities in internalised stigma.
We would recommend that the item “people with RA
should not get married” be removed from future work
using the ISMI-RA as this item was not endorsed by any
participant. We would also recommend a Rasch analysis be
conducted on future ISMI or ISMI-RA data, in order to test
for justification in adding scores to create a total.
At present, the authors are conducting a qualitative
study with a subsample of the current participants to
examine which aspects of internalised stigma impact on
participants’ lives and identity. We hope this will also
provide further validation for the use of the ISMI-RA.
Finally, the authors are also comparing a sample of
patients with a diagnosis RA with a sample of people
who receive care for a psychiatric illness, due to their
previously confirmed experienced internalised stigma
[19, 43, 44, 47–49]. It would be expected from the
current and previous studies that internalised stigma
related to a diagnosis of RA would exist in a compar-
able level to a psychiatric group and may open up new
research avenues to investigate the effects of the diag-
nosis of other long term illnesses on identity and inter-
nalised stigma.
Conclusions
Application of the ISMI-RA appears to be an encouraging
way of measuring internalised stigma in this group. More
research is required to improve the generalisability of these
findings and to compare RA internalised stigma levels to
other long term physical and/or mental illnesses groups.
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